Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
BACKGROUND: We evaluated the association of total and free forms of serum human kallikrein 2 (hK2) and prostate-specific antigen (PSA) with prostate cancers of unfavorable prognosis. METHODS: We retrospectively measured total PSA (tPSA), free PSA (fPSA), and total hK2 (thK2) in preoperative serum s...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2007
|
| _version_ | 1797101064085831680 |
|---|---|
| author | Steuber, T Vickers, A Serio, A Vaisanen, V Haese, A Pettersson, K Eastham, J Scardino, P Huland, H Lilja, H |
| author_facet | Steuber, T Vickers, A Serio, A Vaisanen, V Haese, A Pettersson, K Eastham, J Scardino, P Huland, H Lilja, H |
| author_sort | Steuber, T |
| collection | OXFORD |
| description | BACKGROUND: We evaluated the association of total and free forms of serum human kallikrein 2 (hK2) and prostate-specific antigen (PSA) with prostate cancers of unfavorable prognosis. METHODS: We retrospectively measured total PSA (tPSA), free PSA (fPSA), and total hK2 (thK2) in preoperative serum samples from 867 men [and assessed free hK2 (fhK2) measured in 577 of these men] treated with radical prostatectomy for clinically localized prostate cancer. Associations between biomarker concentrations and extracapsular extension, seminal vesicle invasion, and biochemical recurrence (BCR) were evaluated. A subset of patients with PSA < or =10 microg/L, the group most commonly seen in clinical practice in the US, was analyzed. RESULTS: thK2 was the strongest predictor of extracapsular extension and seminal vesicle invasion (areas under the ROC curve [AUC], 0.662 and 0.719, respectively), followed by tPSA (AUC, 0.654 and 0.663). All biomarkers were significant predictors of BCR. hK2 forms, but not PSA forms, remained highly significant for predicting BCR in the low-PSA group. Combining tPSA, fPSA, and thK2 in a multivariable model improved prediction compared with any biomarker used individually (AUC, 0.711, 0.755, and 0.752 for this combination predicting extracapsular extension, seminal vesicle invasion, and BCR, respectively; P <0.001 for all). CONCLUSIONS: Increased concentrations of hK2 in the blood are significantly associated with unfavorable features of prostate cancer, and thK2 is predictive of locally advanced and recurrent cancer in patients with PSA < or =10 microg/L. Independent of tPSA and fPSA, hK2 predicts unfavorable prognosis. |
| first_indexed | 2024-03-07T05:46:36Z |
| format | Journal article |
| id | oxford-uuid:e76ee12f-4843-4386-bd91-3ae1d78636e1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:46:36Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:e76ee12f-4843-4386-bd91-3ae1d78636e12022-03-27T10:38:37ZComparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e76ee12f-4843-4386-bd91-3ae1d78636e1EnglishSymplectic Elements at Oxford2007Steuber, TVickers, ASerio, AVaisanen, VHaese, APettersson, KEastham, JScardino, PHuland, HLilja, H BACKGROUND: We evaluated the association of total and free forms of serum human kallikrein 2 (hK2) and prostate-specific antigen (PSA) with prostate cancers of unfavorable prognosis. METHODS: We retrospectively measured total PSA (tPSA), free PSA (fPSA), and total hK2 (thK2) in preoperative serum samples from 867 men [and assessed free hK2 (fhK2) measured in 577 of these men] treated with radical prostatectomy for clinically localized prostate cancer. Associations between biomarker concentrations and extracapsular extension, seminal vesicle invasion, and biochemical recurrence (BCR) were evaluated. A subset of patients with PSA < or =10 microg/L, the group most commonly seen in clinical practice in the US, was analyzed. RESULTS: thK2 was the strongest predictor of extracapsular extension and seminal vesicle invasion (areas under the ROC curve [AUC], 0.662 and 0.719, respectively), followed by tPSA (AUC, 0.654 and 0.663). All biomarkers were significant predictors of BCR. hK2 forms, but not PSA forms, remained highly significant for predicting BCR in the low-PSA group. Combining tPSA, fPSA, and thK2 in a multivariable model improved prediction compared with any biomarker used individually (AUC, 0.711, 0.755, and 0.752 for this combination predicting extracapsular extension, seminal vesicle invasion, and BCR, respectively; P <0.001 for all). CONCLUSIONS: Increased concentrations of hK2 in the blood are significantly associated with unfavorable features of prostate cancer, and thK2 is predictive of locally advanced and recurrent cancer in patients with PSA < or =10 microg/L. Independent of tPSA and fPSA, hK2 predicts unfavorable prognosis. |
| spellingShingle | Steuber, T Vickers, A Serio, A Vaisanen, V Haese, A Pettersson, K Eastham, J Scardino, P Huland, H Lilja, H Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. |
| title | Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. |
| title_full | Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. |
| title_fullStr | Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. |
| title_full_unstemmed | Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. |
| title_short | Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. |
| title_sort | comparison of free and total forms of serum human kallikrein 2 and prostate specific antigen for prediction of locally advanced and recurrent prostate cancer |
| work_keys_str_mv | AT steubert comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT vickersa comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT serioa comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT vaisanenv comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT haesea comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT petterssonk comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT easthamj comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT scardinop comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT hulandh comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer AT liljah comparisonoffreeandtotalformsofserumhumankallikrein2andprostatespecificantigenforpredictionoflocallyadvancedandrecurrentprostatecancer |